Medexus Pharmaceuticals held its virtual annual meeting where shareholders elected all nominated directors, approved PricewaterhouseCoopers LLP as auditors, and passed amendments to the company's equity incentive compensation plan. The votes showed strong support, with most nominees receiving over 96% approval. These approvals ensure leadership continuity and support for Medexus's strategic growth in hematology and rare disease treatments. The company will file detailed voting results with Canadian regulators and continue focusing on its expanding product portfolio.
Medexus Pharmaceuticals held its annual meeting of shareholders; here is Pluang's health sector market snapshot as of Sep 25, 2026 03:02 WIB: Of 100 priced health-sector US stocks tradable on Pluang, 33 rose and 67 fell today. Notable movers include Illumina, Inc. (ILMN) at USD 273.73 with a +7.19% change and a typical hold time of 85 days, Moderna, Inc. (MRNA) at USD 194.82 with a +6.98% change, and Ascendis Pharma A/S (ASND) at USD 221.34 with a -6.83% change. The most notable figure is Illumina's +7.19% price increase.
TD SYNNEX posted a record-breaking quarter in Q3 2026 with earnings and revenue surpassing expectations, driven by strong growth in its Hyve Solutions segment and AI infrastructure demand. Despite this, the stock dropped nearly 9% due to a nearly $1 ...
A crypto whale transferred 6,000 Ether (ETH), worth approximately $16.1 million, to five major cryptocurrency exchanges: OKX, Kraken, Gate, Bybit, and Binance. This large transfer places a significant amount of ETH on trading platforms, suggesting th...
Warren Buffett increased his stake in homebuilder Lennar to over 10% immediately after the company missed earnings and lowered its full-year delivery forecast. Despite Lennar's recent weak quarter, Buffett's move signals confidence in the long-term h...
TRON has exceeded $30 trillion in total transaction volume, marking its evolution into a high-throughput settlement network. Daily transactions exceed $30 billion, supported by over 405 million users and 15.6 billion processed transactions, mainly dr...
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
